Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chiappini

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Psychological Medicine|July 23, 2019
New/emerging psychoactive substances and associated psychopathological consequencesF Schifano, F Napoletano, S Chiappini, et al.
Social Neuroscience|August 18, 2023
To bridge or not to bridge: Moral Judgement in Cocaine Use Disorders, a case-control study on human moralityA Mosca, A Miuli, G Mancusi, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 20, 2024
Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysisA Guirguis, S Chiappini, G D Papanti P, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 8, 2024
Comparative safety of prescribed Esketamine and ketamine in relation to renal and urinary disorders: A pharmacovigilance perspectiveS Chiappini, A Guirguis, N Schifano, et al.
The American Journal of Psychiatry|May 3, 2002
Depressive and anxiety disorders in women with HIV infectionMary F Morrison, John M Petitto, Thomas Ten Have, et al.
The American Journal of Psychiatry|October 3, 2002
Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infectionDwight L Evans, Thomas R Ten Have, Steven D Douglas, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Psychological Medicine|July 23, 2019
New/emerging psychoactive substances and associated psychopathological consequencesF Schifano, F Napoletano, S Chiappini, et al.
Social Neuroscience|August 18, 2023
To bridge or not to bridge: Moral Judgement in Cocaine Use Disorders, a case-control study on human moralityA Mosca, A Miuli, G Mancusi, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 20, 2024
Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysisA Guirguis, S Chiappini, G D Papanti P, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 8, 2024
Comparative safety of prescribed Esketamine and ketamine in relation to renal and urinary disorders: A pharmacovigilance perspectiveS Chiappini, A Guirguis, N Schifano, et al.
The American Journal of Psychiatry|May 3, 2002
Depressive and anxiety disorders in women with HIV infectionMary F Morrison, John M Petitto, Thomas Ten Have, et al.
The American Journal of Psychiatry|October 3, 2002
Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infectionDwight L Evans, Thomas R Ten Have, Steven D Douglas, et al.
Pageof 1